Literature DB >> 7423698

Serum calcium and phosphate concentrations and parathyroid morphology in rats treated with vitamin D metabolites.

L Boquist, S E Larsson, R Lorentzon.   

Abstract

The serum concentrations of calcium and phosphate and parathyroid morphology were studied in rats treated with vitamin D metabolites. Twenty hours after a single injection of 1.25-dihydroxycholecalciferol (1.25-DHCC) or 25-hydroxycholecalciferol (25-HCC) the serum calcium and phosphate concentrations were not significantly altered in any group, but the 1.25-DHCC treated rats exhibited an increased number of dark chief cells and occurrence of a few atrophic chief cells. Four to eight weeks after daily injections of the vitamin D metabolites the 1.25-DHCC treated rats exhibited significantly increased serum calcium concentrations and parathyroid glands composed of atrophic and dark chief cells in solid and follicular arrangement, whereas the rats treated with 25-HCC showed unaffected serum calcium concentrations and parathyroid glands composed of solid sheets of light chief cells, often with vacuolated cytoplasm, a few dark chief cells, but no atrophic cells. The findings suggest a direct or indirect suppressive influence of 1.25-DHCC on parathyroid activity in rats.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7423698     DOI: 10.1007/bf00256415

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  15 in total

1.  Response of chick parathyroid glands to the vitamin D metabolites, 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol.

Authors:  H L Henry; A N Taylor; A W Norman
Journal:  J Nutr       Date:  1977-10       Impact factor: 4.798

2.  Ultrastructural changes in the parathyroids of Mongolian gerbils induced experimentally in vitro. Effects of variations in Ca2+ and Mg2+ concentrations.

Authors:  L Boquist
Journal:  Acta Pathol Microbiol Scand A       Date:  1977-03

3.  Low doses of 1,25-dihydroxycholecalciferol increase mature bone mass in adult normal rats.

Authors:  S E Larsson; R Lorentzon; L Boquist
Journal:  Clin Orthop Relat Res       Date:  1977       Impact factor: 4.176

4.  Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol.

Authors:  B S Chertow; D J Baylink; J E Wergedal; M H Su; A W Norman
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

5.  1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol.

Authors:  J C Chan; S B Oldham; M F Holick; H F DeLuca
Journal:  JAMA       Date:  1975-10-06       Impact factor: 56.272

6.  Mast cells in parathyroid glands of hyperparathyroidism.

Authors:  T J Anderson
Journal:  J Clin Pathol       Date:  1974-01       Impact factor: 3.411

7.  Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.

Authors:  L Tougaard; E Sorensen; J Brochner-Mortensen; M S Christensen; P Rodbro; A W Sorensen
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

8.  Influence of 1,25-dihydroxycholecalciferol on parathyroid activity in patients with primary hyperparathyroidism.

Authors:  D Holmlund; L Boquist; S E Larsson; R Lorentzon
Journal:  Acta Chir Scand       Date:  1979

9.  The parathyroid glands of the Mongolian gerbil (Meriones unguiculatus).

Authors:  L Boquist; B Fåhraeus
Journal:  Pathol Eur       Date:  1975

10.  Cytoplasmic and nuclear binding components for 1alpha25-dihydroxyvitamin D3 in chick parathyroid glands.

Authors:  P F Brumbaugh; M R Hughes; M R Haussler
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

View more
  1 in total

1.  Effects of 1,25-dihydroxycholecalciferol on fracture healing. Calcium, phosphate, and zinc in callus and serum.

Authors:  O Andreen; S E Larsson
Journal:  Arch Orthop Trauma Surg       Date:  1984
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.